Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences May 20, 2026 07:00AM
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences Feb 23, 2026 07:00AM
Monte Rosa Therapeutics prices $300 million stock offering at $24 per share Jan 8, 2026 10:49PM
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering Jan 8, 2026 10:49PM
Monte Rosa Therapeutics announces $200 million public stock offering Jan 7, 2026 04:01PM


Jan 7, 2026 04:01PM Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jan 7, 2026 02:25PM TD Cowen on Monte Rosa Therapeutics (GLUE): 'the overall database shows little of concern'
Nov 3, 2025 07:00AM Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Sep 15, 2025 12:02PM TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE) Following Expanded Novartis Deal
Feb 24, 2025 07:00AM Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Oct 28, 2024 12:25PM TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE)
Jun 28, 2024 10:41AM TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE)
May 16, 2024 07:01AM Monte Rosa Therapeutics (GLUE) Prices $100M Share and Warrant offering at $4.70/sh
May 16, 2024 07:00AM Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering
May 15, 2024 04:01PM Monte Rosa Therapeutics (GLUE) Announces Proposed Share and Warrant Offering
May 15, 2024 04:01PM Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jan 31, 2024 07:00AM Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Oct 27, 2023 07:00AM Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Feb 3, 2022 04:30PM Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences
Jul 19, 2021 06:51AM UPDATE: Cowen Starts Monte Rosa Therapeutics (GLUE) at Outperform
Jun 24, 2021 12:21PM Monte Rosa Therapeutics (GLUE) IPO Opens 16% Higher
Jun 24, 2021 05:40AM Monte Rosa Therapeutics (GLUE) Prices 11.7M Share IPO at $19/sh
Jun 23, 2021 08:20PM Monte Rosa Therapeutics Announces Pricing of Initial Public Offering